Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats
European Journal of Neuroscience · 2024
DOI: 10.1111/ejn.16293 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neuroscience, 2024. Verfasst von Melinda Hersey und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medication Development Program, NIDA IRP, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Cocaine, Dopamine, Dopamine Plasma Membrane Transport Proteins, Dopamine Uptake Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Intramural NIH HHS, U.S. Public Health Service.
Abstract (Originalsprache)
Psychostimulant use disorders (PSUD) are prevalent; however, no FDA‐approved medications have been made available for treatment. Previous studies have shown that dual inhibitors of the dopamine transporter (DAT) and sigma receptors significantly reduce the behavioral/reinforcing effects of cocaine, which have been associated with stimulation of extracellular dopamine (DA) levels resulting from DAT inhibition. Here, we employ microdialysis and fast scan cyclic voltammetry (FSCV) procedures to investigate the effects of dual inhibitors of DAT and sigma receptors in combination with cocaine on nucleus accumbens shell (NAS) DA dynamics in naïve male Sprague Dawley rats. In microdialysis studies, administration of rimcazole (3, 10 mg/kg; i.p.) or its structural analog SH 3‐24 (1, 3 mg/kg; i.p.), compounds that are dual inhibitors of DAT and sigma receptors, significantly reduced NAS DA efflux stimulated by increasing doses of cocaine (0.1, 0.3, 1.0 mg/kg; i.v.). Using the same experimental conditions, in FSCV tests, we show that rimcazole pretreatments attenuated cocaine‐induced stimulation of evoked NAS DA release but produced no additional effect on DA clearance rate. Under the same conditions, JJC8‐091, a modafinil analog and dual inhibitor of DAT and sigma receptors, similarly attenuated cocaine‐induced stimulation of evoked NAS DA release but produced no additional effect on DA clearance rate. Our results provide the neurochemical groundwork towards understanding actions of dual inhibitors of DAT and sigma receptors on DA dynamics that likely mediate the behavioral effects of psychostimulants like cocaine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medication Development Program, NIDA IRP, Baltimore, MD, USA.
- Medicinal Chemistry Section, NIDA IRP, Baltimore, MD, USA.
- Psychobiology Section, NIDA IRP, Baltimore, MD, USA.
- Departments of Pharmacology, and Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antonio, TX, USA.
ORCID-Profile: Melinda Hersey, Gianluigi Tanda
Förderung
- NIDA NIH HHS
- Intramural NIH HHS
- U.S. Public Health Service
- National Institute on Drug Abuse
Zitieren
APA
Hersey, M., Mereu, M., Jones, C. S., Bartole, M. K., Chen, A. Y., Cao, J., Hiranita, T., Chun, L. E., Lopez, J. P., Katz, J. L., Newman, A. H., & Tanda, G. (2024). Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16293
Vancouver
Hersey M, Mereu M, Jones CS, Bartole MK, Chen AY, Cao J, et al. Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16293
BibTeX
@article{Hersey2024,
author = {Hersey, Melinda and Mereu, Maddalena and Jones, Claire S and Bartole, Mattingly K and Chen, Andy Y and Cao, Jianjing and Hiranita, Takato and Chun, Lauren E and Lopez, Jessica P and Katz, Jonathan L and Newman, Amy Hauck and Tanda, Gianluigi},
title = {Dual DAT and sigma receptor inhibitors attenuate cocaine effects on nucleus accumbens dopamine dynamics in rats},
journal = {European Journal of Neuroscience},
year = {2024},
doi = {10.1111/ejn.16293}
}
EUVIMED